Neurology & CNS Therapeutics
Prescription Drugs
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
201-500
employees, estimated range
Backers
1
Lux Capital
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
May 2025
Website went live first capture in the Wayback Machine
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.

A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…

About Us Proniras Corporation ("Proniras") is a clinical-stage biotechnology company focused on the development of novel small-molecule…

Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.

Atavistik Bio is a clinical stage biotechnology company developing novel allosteric therapeutics. Our approach enables selective modulation…

What is Neurocarrus?Treating Neurodegenerative Disease and Pain Without Addiction.Neurocarrus is a biotech company developing a novel drug…

Lux Capital 



